Mucoid exopolysaccharide p. aeruginosa immune globulin iv (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
299 | Cystic fibrosis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00004747 (ClinicalTrials.gov) | July 1995 | 24/2/2000 | Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis | Cystic Fibrosis;Bacterial Infections | Drug: mucoid exopolysaccharide P. aeruginosa immune globulin IV | National Center for Research Resources (NCRR) | Vanderbilt University | Completed | 6 Years | N/A | Both | 170 | Phase 2 | NULL |